Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer

Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein...

Full description

Saved in:
Bibliographic Details
Published inGenes & development Vol. 32; no. 1; pp. 58 - 69
Main Authors Hsu, Chih-Chao, Shi, Jiejun, Yuan, Chao, Zhao, Dan, Jiang, Shiming, Lyu, Jie, Wang, Xiaolu, Li, Haitao, Wen, Hong, Li, Wei, Shi, Xiaobing
Format Journal Article
LanguageEnglish
Published United States Cold Spring Harbor Laboratory Press 01.01.2018
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.
AbstractList Hsu et al. show that depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival. Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.
Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for "reader" proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for "reader" proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.
Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for “reader” proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that GAS41 is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.
Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of histone lysine residues and providing binding platforms for "reader" proteins. The bromodomain (BRD) has long been thought to be the sole protein module that recognizes acetylated histones. Recently, we identified the YEATS domain of AF9 (ALL1 fused gene from chromosome 9) as a novel acetyl-lysine-binding module and showed that the ENL (eleven-nineteen leukemia) YEATS domain is an essential acetyl-histone reader in acute myeloid leukemias. The human genome encodes four YEATS domain proteins, including GAS41, a component of chromatin remodelers responsible for H2A.Z deposition onto chromatin; however, the importance of the GAS41 YEATS domain in human cancer remains largely unknown. Here we report that is frequently amplified in human non-small cell lung cancer (NSCLC) and is required for cancer cell proliferation, survival, and transformation. Biochemical and crystal structural studies demonstrate that GAS41 binds to histone H3 acetylated on H3K27 and H3K14, a specificity that is distinct from that of AF9 or ENL. ChIP-seq (chromatin immunoprecipitation [ChIP] followed by high-throughput sequencing) analyses in lung cancer cells reveal that GAS41 colocalizes with H3K27ac and H3K14ac on the promoters of actively transcribed genes. Depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone variant H2A.Z with chromatin and consequently suppresses cancer cell growth and survival both in vitro and in vivo. Overall, our study identifies GAS41 as a histone acetylation reader that promotes histone H2A.Z deposition in NSCLC.
Author Shi, Xiaobing
Jiang, Shiming
Hsu, Chih-Chao
Shi, Jiejun
Lyu, Jie
Wen, Hong
Yuan, Chao
Wang, Xiaolu
Li, Wei
Zhao, Dan
Li, Haitao
AuthorAffiliation 2 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
5 Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China
1 Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
3 Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
4 MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China
6 Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA
AuthorAffiliation_xml – name: 2 Center for Cancer Epigenetics, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
– name: 3 Dan L. Duncan Cancer Center, Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas 77030, USA
– name: 1 Department of Epigenetics and Molecular Carcinogenesis, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
– name: 5 Tsinghua-Peking Joint Center for Life Sciences, Tsinghua University, Beijing 100084, China
– name: 4 MOE Key Laboratory of Protein Sciences, Beijing Advanced Innovation Center for Structural Biology, Department of Basic Medical Sciences, School of Medicine, Tsinghua University, Beijing 100084, China
– name: 6 Genetics and Epigenetics Graduate Program, The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas 77030, USA
Author_xml – sequence: 1
  givenname: Chih-Chao
  surname: Hsu
  fullname: Hsu, Chih-Chao
– sequence: 2
  givenname: Jiejun
  surname: Shi
  fullname: Shi, Jiejun
– sequence: 3
  givenname: Chao
  surname: Yuan
  fullname: Yuan, Chao
– sequence: 4
  givenname: Dan
  surname: Zhao
  fullname: Zhao, Dan
– sequence: 5
  givenname: Shiming
  surname: Jiang
  fullname: Jiang, Shiming
– sequence: 6
  givenname: Jie
  surname: Lyu
  fullname: Lyu, Jie
– sequence: 7
  givenname: Xiaolu
  surname: Wang
  fullname: Wang, Xiaolu
– sequence: 8
  givenname: Haitao
  surname: Li
  fullname: Li, Haitao
– sequence: 9
  givenname: Hong
  surname: Wen
  fullname: Wen, Hong
– sequence: 10
  givenname: Wei
  surname: Li
  fullname: Li, Wei
– sequence: 11
  givenname: Xiaobing
  surname: Shi
  fullname: Shi, Xiaobing
BackLink https://www.ncbi.nlm.nih.gov/pubmed/29437725$$D View this record in MEDLINE/PubMed
BookMark eNp1UctLBCEYlyhqe1w7hscus6mj43gJltgeEAQ9DnURdZxdY0a30Q32v8_aigq6KJ_f7-H3_XbBpg_eAnCI0RhjhE9mqhmXqOQ1zTXfACPMqCgY5XwTjFAtUCHKSuyA3RifEUIVqqptsEMELTknbATSrTVh5l1ywcPQwrmLKTtAZWxaderjWa9gmlt4MbmjGD5OJ_d3sAm9ch4uhtCHZCO8JJPxE2zsIsS1VG7mnxaxV10Hjc1Ht_QzaJQ3dtgHW63qoj34vPfAw_n0_uyyuL65uDqbXBeGsioVRhnW6For01qsUUW0EZbqttVEc0LqxljDGcuTNE0lmDKiRk2dQUqXnLW03AOna93FUvc2w30aVCcXg-vVsJJBOfm7491czsKrZDWpS8GywPGnwBBeljYm2bv4Po3yNiyjJAgRgkSFRYYe_fT6NvladQbQNcAMIcbBttK49LHgbO06iZF8T1TmROU60VzzTBv_oX0p_0N4A_5RpTQ
CitedBy_id crossref_primary_10_1007_s10528_024_10712_w
crossref_primary_10_1007_s13402_022_00675_8
crossref_primary_10_1186_s13072_019_0274_9
crossref_primary_10_1016_j_cbpa_2023_102404
crossref_primary_10_1021_acs_jmedchem_2c01421
crossref_primary_10_3389_fonc_2021_701736
crossref_primary_10_3390_jdb10030028
crossref_primary_10_1016_j_molcel_2023_05_022
crossref_primary_10_1016_j_exphem_2023_06_001
crossref_primary_10_1016_j_phrs_2024_107283
crossref_primary_10_1002_pro_4533
crossref_primary_10_1021_acs_jmedchem_1c00367
crossref_primary_10_1073_pnas_2304103120
crossref_primary_10_1038_s41421_018_0027_0
crossref_primary_10_3389_fendo_2022_972312
crossref_primary_10_1101_gad_348904_121
crossref_primary_10_1016_j_bone_2024_117043
crossref_primary_10_3389_fonc_2024_1384928
crossref_primary_10_3389_fcell_2025_1497290
crossref_primary_10_3390_jpm10040267
crossref_primary_10_1016_j_bcp_2025_116747
crossref_primary_10_1021_acschembio_1c00945
crossref_primary_10_1016_j_lfs_2023_122059
crossref_primary_10_3389_fonc_2021_682762
crossref_primary_10_1084_jem_20182363
crossref_primary_10_1038_s41568_020_00330_0
crossref_primary_10_3389_fcell_2023_1192139
crossref_primary_10_1016_j_csbj_2021_12_027
crossref_primary_10_1016_j_bbagen_2023_130484
crossref_primary_10_1242_dev_201034
crossref_primary_10_1038_s41598_021_82206_3
crossref_primary_10_1002_cbin_11750
crossref_primary_10_1016_j_jbc_2022_102164
crossref_primary_10_3390_ijms21114002
crossref_primary_10_1016_j_gene_2020_144681
crossref_primary_10_1002_hep_31870
crossref_primary_10_1016_j_bmc_2021_116342
crossref_primary_10_1007_s00018_022_04218_0
crossref_primary_10_1038_s41421_019_0103_0
crossref_primary_10_1038_s41576_018_0072_4
crossref_primary_10_1016_j_jmb_2023_168376
crossref_primary_10_1016_j_humgen_2024_201300
crossref_primary_10_1021_acs_accounts_1c00463
crossref_primary_10_1021_acschembio_8b00674
crossref_primary_10_1038_s41467_025_57926_z
crossref_primary_10_1101_gad_351444_123
crossref_primary_10_1093_nar_gkaa1130
crossref_primary_10_1002_advs_202310146
crossref_primary_10_1016_j_nlm_2020_107311
crossref_primary_10_3389_fimmu_2021_641883
crossref_primary_10_1038_s41598_019_50817_6
crossref_primary_10_1038_s41598_024_68348_0
crossref_primary_10_1002_2211_5463_13544
crossref_primary_10_1038_s41568_021_00357_x
crossref_primary_10_1016_j_tibs_2022_04_014
crossref_primary_10_1038_s41576_024_00759_1
crossref_primary_10_1126_science_adl5816
crossref_primary_10_1038_s41580_021_00441_y
crossref_primary_10_1021_acsmedchemlett_9b00460
crossref_primary_10_1186_s12964_024_01823_3
crossref_primary_10_3390_cells9112424
crossref_primary_10_1021_acschembio_4c00240
crossref_primary_10_3390_cancers13123003
crossref_primary_10_1021_acs_jpcb_1c00694
crossref_primary_10_4155_fmc_2020_0082
crossref_primary_10_1016_j_cbpa_2023_102334
crossref_primary_10_1038_s41586_021_03747_1
crossref_primary_10_1038_s41467_022_34861_x
crossref_primary_10_1038_s41467_024_46857_w
crossref_primary_10_2147_OTT_S243823
crossref_primary_10_1038_s41467_023_39735_4
crossref_primary_10_1016_j_ejmech_2023_115093
crossref_primary_10_2139_ssrn_3231848
crossref_primary_10_1002_advs_202307526
crossref_primary_10_1186_s12935_023_03098_z
crossref_primary_10_1038_s42003_020_0898_0
crossref_primary_10_1021_jacs_0c10324
crossref_primary_10_1016_j_chembiol_2021_06_010
crossref_primary_10_1038_s41421_023_00640_1
crossref_primary_10_1111_1462_2920_15725
crossref_primary_10_1158_0008_5472_CAN_23_1836
crossref_primary_10_1039_D3NJ03738J
crossref_primary_10_1158_2159_8290_CD_21_1307
crossref_primary_10_1007_s10142_023_00990_9
crossref_primary_10_1021_acscentsci_3c01419
crossref_primary_10_1177_2472555218809904
crossref_primary_10_1016_j_molcel_2022_11_002
crossref_primary_10_1101_gad_351318_123
crossref_primary_10_1111_nph_15737
crossref_primary_10_18632_aging_205497
Cites_doi 10.1128/MCB.23.17.6086-6102.2003
10.1016/j.molcel.2015.05.009
10.1016/j.mad.2012.11.001
10.3791/51998
10.1038/cr.2016.49
10.1101/gad.1545707
10.1016/j.jmb.2012.10.004
10.1038/20974
10.1016/j.cell.2007.02.005
10.1126/science.1139004
10.1101/gr.118919.110
10.1074/jbc.C110.210211
10.1038/emboj.2010.85
10.1186/1756-8935-6-34
10.1038/nature04835
10.1038/47412
10.1016/j.molcel.2016.06.035
10.1007/s004390050271
10.1002/ijc.23380
10.1101/gad.188359.112
10.18632/oncotarget.7194
10.1186/1471-2164-13-424
10.1074/jbc.M806936200
10.1101/gad.1547707
10.1038/nsmb.1397
10.1126/science.1090701
10.1038/nprot.2008.211
10.1038/nature13045
10.1016/S0968-0004(99)01516-9
10.1126/science.1063127
10.1200/JCO.2012.46.9270
10.1074/jbc.C300389200
10.1186/gb-2008-9-9-r137
10.1101/gad.184705.111
10.1016/j.canlet.2007.10.032
10.1371/journal.pone.0010312
10.1038/s41467-017-01173-4
10.1074/jbc.M500001200
10.1093/hmg/6.11.1817
10.1128/MCB.19.1.855
10.1139/O08-111
10.2217/epi.14.22
10.1007/s00018-009-0199-8
10.1016/j.cell.2007.01.015
10.1158/0008-5472.CAN-04-3703
10.1038/nrm.2016.143
10.4161/epi.5.4.11520
10.1128/MCB.00804-09
10.1016/j.cell.2014.09.049
10.1128/MCB.02185-05
10.1038/nature21687
10.1074/jbc.M703418200
10.1158/0008-5472.CAN-13-1897
10.1371/journal.pbio.0020131
10.1073/pnas.0906539106
10.1016/S1097-2765(03)00497-0
10.1186/gb-2012-13-10-r85
10.1038/nature09139
ContentType Journal Article
Copyright 2018 Hsu et al.; Published by Cold Spring Harbor Laboratory Press.
2018
Copyright_xml – notice: 2018 Hsu et al.; Published by Cold Spring Harbor Laboratory Press.
– notice: 2018
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
DOI 10.1101/gad.303784.117
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic
CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Hsu et al
EISSN 1549-5477
EndPage 69
ExternalDocumentID PMC5828395
29437725
10_1101_gad_303784_117
Genre Research Support, Non-U.S. Gov't
Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: R01 CA193466
– fundername: NHGRI NIH HHS
  grantid: R01 HG007538
– fundername: NCI NIH HHS
  grantid: R01 CA204020
– fundername: CPRIT
  grantid: RP150292
– fundername: ;
– fundername: Texas Tobacco Settlement
– fundername: ;
  grantid: G1719
– fundername: ;
  grantid: 81602476
– fundername: National Post-doctoral Program for Innovative Talents
  grantid: BX201600088
– fundername: National Key R&D Program of China
  grantid: 2016YFA0500700
– fundername: ;
  grantid: R01HG007538; R01CA193466
– fundername: ;
  grantid: 31725014
– fundername: CPRIT
  grantid: RP160237; RP160739
GroupedDBID ---
-DZ
-~X
.55
18M
29H
2WC
39C
4.4
53G
5RE
5VS
85S
AAYXX
ABCQX
ABDIX
ACGFO
ACLKE
ACNCT
ADBBV
ADIYS
ADXHL
AECCQ
AENEX
AETEA
AFFNX
AFOSN
AHPUY
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BTFSW
CITATION
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
H~9
IH2
KQ8
L7B
MV1
N9A
OK1
P2P
R.V
RCX
RHI
RPM
SJN
TAE
TN5
TR2
UHB
W8F
WH7
WOQ
X7M
XSW
YBU
YHG
YKV
YSK
CGR
CUY
CVF
ECM
EIF
NPM
7X8
5PM
ID FETCH-LOGICAL-c456t-cac5db8bacfe1b062bc9e4bffb2b7228dcec755377dd695ac980d8bc9ab375f43
ISSN 0890-9369
1549-5477
IngestDate Thu Aug 21 17:19:41 EDT 2025
Fri Jul 11 03:47:47 EDT 2025
Fri Mar 21 18:55:28 EDT 2025
Tue Jul 01 01:12:08 EDT 2025
Thu Apr 24 23:05:14 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords non-small cell lung cancer
GAS41
H2A.Z
YEATS domain
histone acetylation
Language English
License 2018 Hsu et al.; Published by Cold Spring Harbor Laboratory Press.
This article is distributed exclusively by Cold Spring Harbor Laboratory Press for the first six months after the full-issue publication date (see http://genesdev.cshlp.org/site/misc/terms.xhtml). After six months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c456t-cac5db8bacfe1b062bc9e4bffb2b7228dcec755377dd695ac980d8bc9ab375f43
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Present address: Clinical Molecular Biology Laboratory, The Second Hospital of Shandong University, Jinan, Shandong 250033, China
These authors contributed equally to this work.
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC5828395
PMID 29437725
PQID 2002209619
PQPubID 23479
PageCount 12
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5828395
proquest_miscellaneous_2002209619
pubmed_primary_29437725
crossref_citationtrail_10_1101_gad_303784_117
crossref_primary_10_1101_gad_303784_117
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2018-01-01
20180101
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Genes & development
PublicationTitleAlternate Genes Dev
PublicationYear 2018
Publisher Cold Spring Harbor Laboratory Press
Publisher_xml – name: Cold Spring Harbor Laboratory Press
References (2021111620065702000_32.1.58.42) 2009; 12
(2021111620065702000_32.1.58.47) 2015; 7
2021111620065702000_32.1.58.30
(2021111620065702000_32.1.58.58) 2016; 7
2021111620065702000_32.1.58.32
2021111620065702000_32.1.58.34
2021111620065702000_32.1.58.33
2021111620065702000_32.1.58.36
2021111620065702000_32.1.58.35
2021111620065702000_32.1.58.8
2021111620065702000_32.1.58.9
2021111620065702000_32.1.58.37
2021111620065702000_32.1.58.39
2021111620065702000_32.1.58.41
2021111620065702000_32.1.58.40
2021111620065702000_32.1.58.43
(2021111620065702000_32.1.58.52) 2017; 543
2021111620065702000_32.1.58.45
2021111620065702000_32.1.58.44
2021111620065702000_32.1.58.46
2021111620065702000_32.1.58.49
2021111620065702000_32.1.58.48
2021111620065702000_32.1.58.50
2021111620065702000_32.1.58.51
2021111620065702000_32.1.58.10
2021111620065702000_32.1.58.54
2021111620065702000_32.1.58.53
2021111620065702000_32.1.58.12
2021111620065702000_32.1.58.56
2021111620065702000_32.1.58.11
2021111620065702000_32.1.58.55
2021111620065702000_32.1.58.14
2021111620065702000_32.1.58.13
2021111620065702000_32.1.58.57
2021111620065702000_32.1.58.16
2021111620065702000_32.1.58.15
2021111620065702000_32.1.58.59
2021111620065702000_32.1.58.18
2021111620065702000_32.1.58.17
2021111620065702000_32.1.58.4
2021111620065702000_32.1.58.5
2021111620065702000_32.1.58.19
2021111620065702000_32.1.58.6
2021111620065702000_32.1.58.7
2021111620065702000_32.1.58.1
2021111620065702000_32.1.58.2
2021111620065702000_32.1.58.3
(2021111620065702000_32.1.58.24) 2012; 133
(2021111620065702000_32.1.58.31) 2017; 8
(2021111620065702000_32.1.58.61) 2016; 26
2021111620065702000_32.1.58.60
2021111620065702000_32.1.58.21
(2021111620065702000_32.1.58.38) 2011; 58
2021111620065702000_32.1.58.20
2021111620065702000_32.1.58.23
2021111620065702000_32.1.58.22
2021111620065702000_32.1.58.25
2021111620065702000_32.1.58.27
2021111620065702000_32.1.58.26
2021111620065702000_32.1.58.29
2021111620065702000_32.1.58.28
25408172 - J Vis Exp. 2014 Oct 27;(92):e51998
17671089 - Genes Dev. 2007 Aug 1;21(15):1869-81
15604268 - Cancer Res. 2004 Dec 15;64(24):9027-34
27103431 - Cell Res. 2016 May;26(5):629-32
25111486 - Epigenomics. 2014 Jun;6(3):329-39
24279307 - Epigenetics Chromatin. 2013 Oct 16;6(1):34
9302258 - Hum Mol Genet. 1997 Oct;6(11):1817-22
19936620 - Cell Mol Life Sci. 2010 Feb;67(4):611-28
17320507 - Cell. 2007 Feb 23;128(4):693-705
24170126 - Cancer Res. 2013 Dec 15;73(24):7301-12
22426530 - Genes Dev. 2012 Mar 15;26(6):527-41
21317290 - J Biol Chem. 2011 Apr 1;286(13):10911-7
28053347 - Nat Rev Mol Cell Biol. 2017 Apr;18(4):246-262
22920947 - BMC Genomics. 2012 Aug 24;13:424
14690608 - Mol Cell. 2003 Dec;12(6):1565-76
28241141 - Nature. 2017 Mar 9;543(7644):265-269
16705155 - Mol Cell Biol. 2006 Jun;26(11):4006-16
26051178 - Mol Cell. 2015 Jul 2;59(1):75-88
18327268 - Nat Struct Mol Biol. 2008 Apr;15(4):364-72
23034477 - Genome Biol. 2012 Oct 03;13(10):R85
19736624 - Curr Opin Drug Discov Devel. 2009 Sep;12(5):659-65
10637607 - Trends Biochem Sci. 2000 Jan;25(1):15-9
16728974 - Nature. 2006 Jul 6;442(7098):96-9
18160213 - Cancer Lett. 2008 Feb 18;260(1-2):37-47
22713874 - Genes Dev. 2012 Jun 15;26(12):1376-91
21788347 - Genome Res. 2012 Feb;22(2):307-21
25705384 - F1000Prime Rep. 2015 Jan 05;7:01
11498575 - Science. 2001 Aug 10;293(5532):1074-80
12963728 - J Biol Chem. 2003 Oct 31;278(44):42733-6
17617668 - J Biol Chem. 2007 Sep 7;282(36):26132-9
20351180 - Mol Cell Biol. 2010 Jun;30(11):2750-61
19966225 - Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21573-8
20473270 - EMBO J. 2010 Jun 16;29(12):2014-25
18838386 - J Biol Chem. 2008 Dec 5;283(49):33808-15
17320508 - Cell. 2007 Feb 23;128(4):707-19
15647280 - J Biol Chem. 2005 Apr 8;280(14 ):13665-70
27477906 - Mol Cell. 2016 Aug 4;63(3):470-84
14645854 - Science. 2004 Jan 16;303(5656):343-8
17510366 - Science. 2007 May 18;316(5827):1050-4
23401443 - J Clin Oncol. 2013 Mar 10;31(8):992-1001
25417107 - Cell. 2014 Oct 23;159(3):558-71
8882887 - Hum Genet. 1996 Nov;98(5):625-8
18214854 - Int J Cancer. 2008 May 15;122(10 ):2233-41
22068108 - Acta Biochim Pol. 2011;58(4):529-34
9858608 - Mol Cell Biol. 1999 Jan;19(1):855-63
23146670 - Mech Ageing Dev. 2012 Nov-Dec;133(11-12):686-94
10638745 - Nature. 2000 Jan 6;403(6765):41-5
23063713 - J Mol Biol. 2012 Dec 14;424(5):328-38
17575053 - Genes Dev. 2007 Jun 15;21(12):1519-29
18798982 - Genome Biol. 2008;9(9):R137
19234524 - Biochem Cell Biol. 2009 Feb;87(1):65-75
20364108 - Epigenetics. 2010 May 16;5(4):267-72
20613843 - Nature. 2010 Jul 8;466(7303):258-62
24590075 - Nature. 2014 Apr 10;508(7495):263-8
29057918 - Nat Commun. 2017 Oct 20;8(1):1088
12917332 - Mol Cell Biol. 2003 Sep;23(17):6086-102
20421987 - PLoS One. 2010 Apr 22;5(4):e10312
15045029 - PLoS Biol. 2004 May;2(5):E131
26863632 - Oncotarget. 2016 Mar 8;7(10 ):11412-23
10365964 - Nature. 1999 Jun 3;399(6735):491-6
19131956 - Nat Protoc. 2009;4(1):44-57
References_xml – ident: 2021111620065702000_32.1.58.25
  doi: 10.1128/MCB.23.17.6086-6102.2003
– ident: 2021111620065702000_32.1.58.51
  doi: 10.1016/j.molcel.2015.05.009
– volume: 133
  start-page: 686
  year: 2012
  ident: 2021111620065702000_32.1.58.24
  article-title: Decrease of p400 ATPase complex and loss of H2A.Z within the p21 promoter occur in senescent IMR-90 human fibroblasts
  publication-title: Mech Ageing Dev
  doi: 10.1016/j.mad.2012.11.001
– volume: 58
  start-page: 529
  year: 2011
  ident: 2021111620065702000_32.1.58.38
  article-title: Direct interaction of Gas41 and Myc encoded by amplified genes in nervous system tumours
  publication-title: Acta Biochim Pol
– ident: 2021111620065702000_32.1.58.2
  doi: 10.3791/51998
– volume: 26
  start-page: 629
  year: 2016
  ident: 2021111620065702000_32.1.58.61
  article-title: YEATS2 is a selective histone crotonylation reader
  publication-title: Cell Res
  doi: 10.1038/cr.2016.49
– ident: 2021111620065702000_32.1.58.11
  doi: 10.1101/gad.1545707
– ident: 2021111620065702000_32.1.58.1
  doi: 10.1016/j.jmb.2012.10.004
– ident: 2021111620065702000_32.1.58.7
  doi: 10.1038/20974
– ident: 2021111620065702000_32.1.58.21
  doi: 10.1016/j.cell.2007.02.005
– volume: 12
  start-page: 659
  year: 2009
  ident: 2021111620065702000_32.1.58.42
  article-title: The role of human bromodomains in chromatin biology and gene transcription
  publication-title: Curr Opin Drug Discov Devel
– ident: 2021111620065702000_32.1.58.27
  doi: 10.1126/science.1139004
– ident: 2021111620065702000_32.1.58.50
  doi: 10.1101/gr.118919.110
– ident: 2021111620065702000_32.1.58.36
  doi: 10.1074/jbc.C110.210211
– ident: 2021111620065702000_32.1.58.6
  doi: 10.1038/emboj.2010.85
– ident: 2021111620065702000_32.1.58.19
  doi: 10.1186/1756-8935-6-34
– ident: 2021111620065702000_32.1.58.44
  doi: 10.1038/nature04835
– ident: 2021111620065702000_32.1.58.46
  doi: 10.1038/47412
– ident: 2021111620065702000_32.1.58.29
  doi: 10.1016/j.molcel.2016.06.035
– ident: 2021111620065702000_32.1.58.8
  doi: 10.1007/s004390050271
– ident: 2021111620065702000_32.1.58.15
  doi: 10.1002/ijc.23380
– ident: 2021111620065702000_32.1.58.40
  doi: 10.1101/gad.188359.112
– volume: 7
  start-page: 11412
  year: 2016
  ident: 2021111620065702000_32.1.58.58
  article-title: Oncogenic potential of histone-variant H2A.Z.1 and its regulatory role in cell cycle and epithelial-mesenchymal transition in liver cancer
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.7194
– ident: 2021111620065702000_32.1.58.18
  doi: 10.1186/1471-2164-13-424
– ident: 2021111620065702000_32.1.58.54
  doi: 10.1074/jbc.M806936200
– ident: 2021111620065702000_32.1.58.17
  doi: 10.1101/gad.1547707
– ident: 2021111620065702000_32.1.58.48
  doi: 10.1038/nsmb.1397
– ident: 2021111620065702000_32.1.58.32
  doi: 10.1126/science.1090701
– ident: 2021111620065702000_32.1.58.13
  doi: 10.1038/nprot.2008.211
– ident: 2021111620065702000_32.1.58.56
  doi: 10.1038/nature13045
– ident: 2021111620065702000_32.1.58.3
  doi: 10.1016/S0968-0004(99)01516-9
– ident: 2021111620065702000_32.1.58.16
  doi: 10.1126/science.1063127
– ident: 2021111620065702000_32.1.58.49
  doi: 10.1200/JCO.2012.46.9270
– ident: 2021111620065702000_32.1.58.4
  doi: 10.1074/jbc.C300389200
– ident: 2021111620065702000_32.1.58.60
  doi: 10.1186/gb-2008-9-9-r137
– volume: 7
  start-page: 01
  year: 2015
  ident: 2021111620065702000_32.1.58.47
  article-title: H2A.Z: a molecular rheostat for transcriptional control
  publication-title: F1000prime Rep
– ident: 2021111620065702000_32.1.58.45
  doi: 10.1101/gad.184705.111
– ident: 2021111620065702000_32.1.58.37
  doi: 10.1016/j.canlet.2007.10.032
– ident: 2021111620065702000_32.1.58.12
  doi: 10.1371/journal.pone.0010312
– volume: 8
  start-page: 1088
  year: 2017
  ident: 2021111620065702000_32.1.58.31
  article-title: YEATS2 links histone acetylation to tumorigenesis of non-small cell lung cancer
  publication-title: Nat Commun
  doi: 10.1038/s41467-017-01173-4
– ident: 2021111620065702000_32.1.58.5
  doi: 10.1074/jbc.M500001200
– ident: 2021111620065702000_32.1.58.9
  doi: 10.1093/hmg/6.11.1817
– ident: 2021111620065702000_32.1.58.14
  doi: 10.1128/MCB.19.1.855
– ident: 2021111620065702000_32.1.58.43
  doi: 10.1139/O08-111
– ident: 2021111620065702000_32.1.58.53
  doi: 10.2217/epi.14.22
– ident: 2021111620065702000_32.1.58.33
  doi: 10.1007/s00018-009-0199-8
– ident: 2021111620065702000_32.1.58.26
  doi: 10.1016/j.cell.2007.01.015
– ident: 2021111620065702000_32.1.58.41
  doi: 10.1158/0008-5472.CAN-04-3703
– ident: 2021111620065702000_32.1.58.10
  doi: 10.1038/nrm.2016.143
– ident: 2021111620065702000_32.1.58.30
  doi: 10.4161/epi.5.4.11520
– ident: 2021111620065702000_32.1.58.35
  doi: 10.1128/MCB.00804-09
– ident: 2021111620065702000_32.1.58.28
  doi: 10.1016/j.cell.2014.09.049
– ident: 2021111620065702000_32.1.58.34
  doi: 10.1128/MCB.02185-05
– volume: 543
  start-page: 265
  year: 2017
  ident: 2021111620065702000_32.1.58.52
  article-title: ENL links histone acetylation to oncogenic gene expression in acute myeloid leukaemia
  publication-title: Nature
  doi: 10.1038/nature21687
– ident: 2021111620065702000_32.1.58.57
  doi: 10.1074/jbc.M703418200
– ident: 2021111620065702000_32.1.58.39
  doi: 10.1158/0008-5472.CAN-13-1897
– ident: 2021111620065702000_32.1.58.20
  doi: 10.1371/journal.pbio.0020131
– ident: 2021111620065702000_32.1.58.55
  doi: 10.1073/pnas.0906539106
– ident: 2021111620065702000_32.1.58.22
  doi: 10.1016/S1097-2765(03)00497-0
– ident: 2021111620065702000_32.1.58.23
  doi: 10.1186/gb-2012-13-10-r85
– ident: 2021111620065702000_32.1.58.59
  doi: 10.1038/nature09139
– reference: 17575053 - Genes Dev. 2007 Jun 15;21(12):1519-29
– reference: 17320507 - Cell. 2007 Feb 23;128(4):693-705
– reference: 19966225 - Proc Natl Acad Sci U S A. 2009 Dec 22;106(51):21573-8
– reference: 26863632 - Oncotarget. 2016 Mar 8;7(10 ):11412-23
– reference: 10365964 - Nature. 1999 Jun 3;399(6735):491-6
– reference: 25408172 - J Vis Exp. 2014 Oct 27;(92):e51998
– reference: 22920947 - BMC Genomics. 2012 Aug 24;13:424
– reference: 18838386 - J Biol Chem. 2008 Dec 5;283(49):33808-15
– reference: 24279307 - Epigenetics Chromatin. 2013 Oct 16;6(1):34
– reference: 19936620 - Cell Mol Life Sci. 2010 Feb;67(4):611-28
– reference: 18798982 - Genome Biol. 2008;9(9):R137
– reference: 23146670 - Mech Ageing Dev. 2012 Nov-Dec;133(11-12):686-94
– reference: 23401443 - J Clin Oncol. 2013 Mar 10;31(8):992-1001
– reference: 15647280 - J Biol Chem. 2005 Apr 8;280(14 ):13665-70
– reference: 8882887 - Hum Genet. 1996 Nov;98(5):625-8
– reference: 9302258 - Hum Mol Genet. 1997 Oct;6(11):1817-22
– reference: 14645854 - Science. 2004 Jan 16;303(5656):343-8
– reference: 23063713 - J Mol Biol. 2012 Dec 14;424(5):328-38
– reference: 20364108 - Epigenetics. 2010 May 16;5(4):267-72
– reference: 15604268 - Cancer Res. 2004 Dec 15;64(24):9027-34
– reference: 18327268 - Nat Struct Mol Biol. 2008 Apr;15(4):364-72
– reference: 20613843 - Nature. 2010 Jul 8;466(7303):258-62
– reference: 21788347 - Genome Res. 2012 Feb;22(2):307-21
– reference: 18214854 - Int J Cancer. 2008 May 15;122(10 ):2233-41
– reference: 10638745 - Nature. 2000 Jan 6;403(6765):41-5
– reference: 14690608 - Mol Cell. 2003 Dec;12(6):1565-76
– reference: 19234524 - Biochem Cell Biol. 2009 Feb;87(1):65-75
– reference: 25705384 - F1000Prime Rep. 2015 Jan 05;7:01
– reference: 26051178 - Mol Cell. 2015 Jul 2;59(1):75-88
– reference: 24590075 - Nature. 2014 Apr 10;508(7495):263-8
– reference: 16728974 - Nature. 2006 Jul 6;442(7098):96-9
– reference: 24170126 - Cancer Res. 2013 Dec 15;73(24):7301-12
– reference: 29057918 - Nat Commun. 2017 Oct 20;8(1):1088
– reference: 19131956 - Nat Protoc. 2009;4(1):44-57
– reference: 12963728 - J Biol Chem. 2003 Oct 31;278(44):42733-6
– reference: 17617668 - J Biol Chem. 2007 Sep 7;282(36):26132-9
– reference: 27103431 - Cell Res. 2016 May;26(5):629-32
– reference: 28053347 - Nat Rev Mol Cell Biol. 2017 Apr;18(4):246-262
– reference: 27477906 - Mol Cell. 2016 Aug 4;63(3):470-84
– reference: 17510366 - Science. 2007 May 18;316(5827):1050-4
– reference: 9858608 - Mol Cell Biol. 1999 Jan;19(1):855-63
– reference: 22713874 - Genes Dev. 2012 Jun 15;26(12):1376-91
– reference: 22068108 - Acta Biochim Pol. 2011;58(4):529-34
– reference: 23034477 - Genome Biol. 2012 Oct 03;13(10):R85
– reference: 11498575 - Science. 2001 Aug 10;293(5532):1074-80
– reference: 17671089 - Genes Dev. 2007 Aug 1;21(15):1869-81
– reference: 20351180 - Mol Cell Biol. 2010 Jun;30(11):2750-61
– reference: 16705155 - Mol Cell Biol. 2006 Jun;26(11):4006-16
– reference: 28241141 - Nature. 2017 Mar 9;543(7644):265-269
– reference: 15045029 - PLoS Biol. 2004 May;2(5):E131
– reference: 25111486 - Epigenomics. 2014 Jun;6(3):329-39
– reference: 18160213 - Cancer Lett. 2008 Feb 18;260(1-2):37-47
– reference: 12917332 - Mol Cell Biol. 2003 Sep;23(17):6086-102
– reference: 21317290 - J Biol Chem. 2011 Apr 1;286(13):10911-7
– reference: 20473270 - EMBO J. 2010 Jun 16;29(12):2014-25
– reference: 19736624 - Curr Opin Drug Discov Devel. 2009 Sep;12(5):659-65
– reference: 10637607 - Trends Biochem Sci. 2000 Jan;25(1):15-9
– reference: 20421987 - PLoS One. 2010 Apr 22;5(4):e10312
– reference: 17320508 - Cell. 2007 Feb 23;128(4):707-19
– reference: 25417107 - Cell. 2014 Oct 23;159(3):558-71
– reference: 22426530 - Genes Dev. 2012 Mar 15;26(6):527-41
SSID ssj0006066
Score 2.5451388
Snippet Histone acetylation is associated with active transcription in eukaryotic cells. It helps to open up the chromatin by neutralizing the positive charge of...
Hsu et al. show that depletion of GAS41 or disruption of the interaction between its YEATS domain and acetylated histones impairs the association of histone...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 58
SubjectTerms Acetylation
Carcinoma, Non-Small-Cell Lung - genetics
Carcinoma, Non-Small-Cell Lung - metabolism
Carcinoma, Non-Small-Cell Lung - pathology
Cell Line, Tumor
Cell Proliferation
Gene Amplification
Genes, cdc
Histones - metabolism
Histones - physiology
Humans
Lung Neoplasms - genetics
Lung Neoplasms - metabolism
Lung Neoplasms - pathology
Promoter Regions, Genetic
Protein Interaction Domains and Motifs
Research Paper
Transcription Factors - chemistry
Transcription Factors - genetics
Transcription Factors - metabolism
Transcription Factors - physiology
Title Recognition of histone acetylation by the GAS41 YEATS domain promotes H2A.Z deposition in non-small cell lung cancer
URI https://www.ncbi.nlm.nih.gov/pubmed/29437725
https://www.proquest.com/docview/2002209619
https://pubmed.ncbi.nlm.nih.gov/PMC5828395
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwELfKEBIviG_Kl4yExEPl0aZOYz9WY6gMwQPrpG0vVWzHtGhL0Zo8lL-CP5k723HTbUiDFytKbCf2_eK7853vCHkrrBUmTzNmFLeMCyikyRSzEsAjpSqGEk8jf_k6mhzxg-P0uNP53fJaqiu1q39de67kf6gK94CueEr2HygbO4UbcA30hRIoDOWNaPyt8f4JQh-GCSgxPkZRrb2Pm5MuEQnjQz7oneyPp4c9szzPF84zC8hUrHqTZLx7ii6xwX8Lt0DKZclW52i2xp393lmNR3MRIBdtaRZjVq8ceMzG9ygCZVV7e_5izvbm-TLu5bg0wr2DRfGjjsg8qfPG-h8rnsJ1OAXf3psYiNbeRFjCZJ9hykDPbcISyyVLeUjeEtbgzR5nxJpfUH1c98CafT9XF32XbOB7bnaBH2eCoyF6w94ak_4lrhd9EZ0W1B_MoP3Mt8cA6LfI7QQUD8yJ8eHT58jbUd1zekkYVwgDCu3fb79_W8y5ortcdsFtyTTT--ReUEbo2CPrAekU5UNyx6cnXT8iVQtfdGlpwBdt4YuqNQV8UYcv6vBFPb5ogy_q8EU3-KLwMOKLIr4o4ot6fD0mRx_3p3sTFrJ0MA3Cd8V0rlOjhMq1LQaqP0qUlgVX1qpEwQQKGKLO0nSYZcaMZJprKfpGQKVcDbPU8uETsgMvLZ4RCtNqBLBgqzMNijQXNgGFQmltR3IAinWXsGZSZzqEsMdMKmez64nYJe9i_Z8-eMtfa75paDSD9RWHnpfFsl5hmtYkwbxIskueeprFvhLJYVgJfFe2Rc1YAWO3bz8pF3MXwx2t1UOZPr_xF74gdzd_2EuyU13UxSuQhyv12kH0DxJ-teI
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Recognition+of+histone+acetylation+by+the+GAS41+YEATS+domain+promotes+H2A.Z+deposition+in+non-small+cell+lung+cancer&rft.jtitle=Genes+%26+development&rft.au=Hsu%2C+Chih-Chao&rft.au=Shi%2C+Jiejun&rft.au=Yuan%2C+Chao&rft.au=Zhao%2C+Dan&rft.date=2018-01-01&rft.issn=0890-9369&rft.eissn=1549-5477&rft.volume=32&rft.issue=1&rft.spage=58&rft.epage=69&rft_id=info:doi/10.1101%2Fgad.303784.117&rft.externalDBID=n%2Fa&rft.externalDocID=10_1101_gad_303784_117
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0890-9369&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0890-9369&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0890-9369&client=summon